trial · primary record
eloralintide and tirzepatide
Obesity
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 2115 |
| Primary completion | 2029-11 |
| Primary endpoint | Percent Change from Baseline in Body Weight |
| Registry ID | NCT07881432 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:46.351Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07881432
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- eloralintide and tirzepatide · compound